近几年来慢性肾脏病(Chronic kidney disease, CKD)的患病率持续上升,据统计,我国CKD的患病率约10.8%,终末期肾病(End stage of renal disease, ESRD)患者高达300万,接受透析的约60万,其中腹膜透析患者约占14%。腹膜透析(Peritoneal dialysis, PD)有很大优势,但长期PD会使腹膜的结构和功能发生变化,引起腹膜纤维化,最终造成超滤衰竭(Ultrafiltration failure, UFF),这一过程是导致PD失败的主要原因。本文从PD相关性腹膜纤维化的发生机制入手,介绍诊断和治疗该病的最新研究进展,包括细胞、动物实验层面,中医药治疗等方面,为进一步研究PD相关腹膜纤维化的防治问题提供临床证据。
In recent years, the prevalence of chronic kidney disease (CKD) has continued to rise, according to statistics, the prevalence of CKD in China is about 10.8%, end-stage kidney disease (ESRD) patients are as high as 3 million, about 600,000 people on dialysis, of which peritoneal dialysis patients account for about 14%. Peritoneal dialysis (PD) has great advantages, but long-term PD causes changes in the structure and function of the peritoneal membrane, causing peritoneal fibrosis and ultimately ultrafiltration failure (UFF), a process that is the main cause of PD failure. Starting with the mechanism of PD-related peritoneal fibrosis, this paper introduces the latest research progress in the diagnosis and treatment of the disease, including the experimental level of cells and animals, and the treatment of traditional Chinese medicine, so as to provide clinical evidence for further study of the prevention and treatment of PD-related peritoneal fibrosis.
In recent years, the prevalence of chronic kidney disease (CKD) has continued to rise, according to statistics, the prevalence of CKD in China is about 10.8%, end-stage kidney disease (ESRD) patients are as high as 3 million, about 600,000 people on dialysis, of which peritoneal dialysis patients account for about 14%. Peritoneal dialysis (PD) has great advantages, but long-term PD causes changes in the structure and function of the peritoneal membrane, causing peritoneal fibrosis and ultimately ultrafiltration failure (UFF), a process that is the main cause of PD failure. Starting with the mechanism of PD-related peritoneal fibrosis, this paper introduces the latest research progress in the diagnosis and treatment of the disease, including the experimental level of cells and animals, and the treatment of traditional Chinese medicine, so as to provide clinical evidence for further study of the prevention and treatment of PD-related peritoneal fibrosis.
参考文献ReferencesHiramatsu, T., Okumura, S., Asano, Y., et al. (2019) Quality of Life and Emotional Distress in Peritoneal Dialysis and Hemodialysis Patients. Therapeutic Apheresis and Dialysis, 24, 366-372. <br>https://doi.org/10.1111/1744-9987.13450Klarenbach, S.W., Tonelli, M., Chui, B. and Manns, B.J. (2014) Economic Evaluation of Dialysis Therapies. Nature Reviews Nephrology, 10, 644-652. <br>https://doi.org/10.1038/nrneph.2014.145Kendrick, J. and Teitelbaum, I. (2010) Strategies for Improving Long-Term Survival in Peritoneal Dialysis Patients. Clinical Journal of the American Society of Nephrology, 5, 1123-1131. <br>https://doi.org/10.2215/CJN.04300709Krediet, R.T., Lindholm, B. and Rippe, B. (2000) Pathophysiology of Peritoneal Membrane Failure. Peritoneal Dialysis International, 20, S22-S42. <br>https://doi.org/10.1177/089686080002004S03方炜, 钱家麒, 余志远, 林爱武, 陈诗书. 腹膜透析对人腹膜形态结构的影响[J]. 中华肾脏病杂志, 2002(6): 41-45.Qayyum, A., Oei, E.L., Paudel, K. and Fan, S.L. (2015) Increasing the Use of Biocompatible, Glucose-Free Peritoneal Dialysis Solutions. World Journal of Nephrology, 4, 92-97. <br>https://doi.org/10.5527/wjn.v4.i1.92Morelle, J., Sow, A., Hautem, N., et al. (2015) Interstitial Fibrosis Restricts Osmotic Water Transport in Encapsulating Peritoneal Sclerosis. Journal of the American Society of Nephrology, 26, 2521-2533.
<br>https://doi.org/10.1681/ASN.2014090939Devuyst, O., Margetts, P.J. and Topley, N. (2010) The Pathophysiology of the Peritoneal Membrane. Journal of the American Society of Nephrology, 21, 1077-1085. <br>https://doi.org/10.1681/ASN.2009070694Schilte, M.N., Celie, J.W., Wee, P.M., Beelen, R.H. and van den Born, J. (2009) Factors Contributing to Peritoneal Tissue Remodeling in Peritoneal Dialysis. Peritoneal Dialysis International, 29, 605-617.
<br>https://doi.org/10.1177/089686080902900604De Vriese, A.S., Tilton, R.G., Stephan, C.C. and Lameire, N.H. (2001) Vascular Endothelial Growth Factor Is Essential for Hyperglycemia-Induced Structural and Functional Alterations of the Peritoneal Membrane. Journal of the American Society of Nephrology, 12, 1734-1741. <br>https://doi.org/10.1681/ASN.V1281734Aroeira, L.S., Aguilera, A., Selgas, R., et al. (2005) Mesenchymal Conversion of Mesothelial Cells as a Mechanism Responsible for High Solute Transport Rate in Peritoneal Dialysis: Role of Vascular Endothelial Growth Factor. American Journal of Kidney Diseases, 46, 938-948. <br>https://doi.org/10.1053/j.ajkd.2005.08.011Kariya, T., Nishimura, H., Mizuno, M., et al. (2018) TGF-β1-VEGF-A Pathway Induces Neoangiogenesis with Peritoneal Fibrosis in Patients Undergoing Peritoneal Dialysis. The American Journal of Physiology-Renal Physiology, 314, F167-F180. <br>https://doi.org/10.1152/ajprenal.00052.2017Kitterer, D., Latus, J., Ulmer, C., Fritz, P., Biegger, D., Ott, G., Alscher, M.D., Witowski, J., Kawka, E., Jörres, A., Seeger, H., Segerer, S. and Braun, N. (2015) Activation of Nuclear Factor of Activated T Cells 5 in the Peritoneal Membrane of Uremic Patients. The American Journal of Physiology-Renal Physiology, 308, F1247-F1258.
<br>https://doi.org/10.1152/ajprenal.00617.2014Aroeira, L.S., Aguilera, A., Sánchez-Tomero, J.A., Bajo, M.A., del Peso, G., Jiménez-Heffernan, J.A., Selgas, R. and López-Cabrera, M. (2007) Epithelial to Mesenchymal Transition and Peritoneal Membrane Failure in Peritoneal Dialysis Patients: Pathologic Significance and Potential Therapeutic Interventions. Journal of the American Society of Nephrology, 18, 2004-2013. <br>https://doi.org/10.1681/ASN.2006111292Derynck, R. and Zhang, Y.E. (2003) Smad-Dependent and Smad-Independent Pathways in TGF-Beta Family Signalling. Nature, 425, 577-584. <br>https://doi.org/10.1038/nature02006Peng, W., Dou, X., Hao, W., et al. (2013) Smad7 Gene Transfer Attenuates Angiogenesis in Peritoneal Dialysis Rats. Nephrology (Carlton), 18, 138-147. <br>https://doi.org/10.1111/nep.12017Wang, X., Li, X., Ye, L., Chen, W. and Yu, X. (2013) Smad7 Inhibits TGF-β1-Induced MCP-1 Upregulation through a MAPK/p38 Pathway in Rat Peritoneal Mesothelial Cells. International Urology and Nephrology, 45, 899-907.
<br>https://doi.org/10.1007/s11255-012-0350-6Liang, H., Xu, F., Zhang, T., et al. (2018) Inhibition of IL-18 Reduces Renal Fibrosis after Ischemia-Reperfusion. Biomedicine & Pharmacotherapy, 106, 879-889. <br>https://doi.org/10.1016/j.biopha.2018.07.031Guo, J., Gu, N., Chen, J., et al. (2013) Neutralization of Interleukin-1 Beta Attenuates Silica-Induced Lung Inflammation and Fibrosis in C57BL/6 Mice. Archives of Toxicology, 87, 1963-1973. <br>https://doi.org/10.1007/s00204-013-1063-zLiakopoulos, V., Roumeliotis, S., Gorny, X., Eleftheriadis, T. and Mertens, P.R. (2017) Oxidative Stress in Patients Undergoing Peritoneal Dialysis: A Current Review of the Literature. Oxidative Medicine and Cellular Longevity, 2017, Article ID: 3494867. <br>https://doi.org/10.1155/2017/3494867Puttinger, H. (2013) Peritoneal Dialysis—An Ideal Initial Dialysis Mode. Wiener Medizinische Wochenschrift, 163, 271-279. <br>https://doi.org/10.1007/s10354-013-0200-xKato, S., Yuzawa, Y., Tsuboi, N., et al. (2004) Endotoxin-Induced Chemokine Expression in Murine Peritoneal Mesothelial Cells: The Role of Toll-Like Receptor 4. Journal of the American Society of Nephrology, 15, 1289-1299.Hautem, N., Morelle, J., Sow, A., et al. (2017) The NLRP3 Inflammasome Has a Critical Role in Peritoneal Dialysis-Related Peritonitis. Journal of the American Society of Nephrology, 28, 2038-2052.
<br>https://doi.org/10.1681/ASN.2016070729Pecoits-Filho, R., Araújo, M.R., Lindholm, B., et al. (2002) Plasma and Dialysate IL-6 and VEGF Concentrations Are Associated with High Peritoneal Solute Transport Rate. Nephrology Dialysis Transplantation, 17, 1480-1486.
<br>https://doi.org/10.1093/ndt/17.8.1480Yang, X., Yan, H., Jiang, N., et al. (2020) IL-6 Trans-Signaling Drives a STAT3-Dependent Pathway That Leads to Structural Alterations of the Peritoneal Membrane. The American Journal of Physiology-Renal Physiology, 318, F338-F353. <br>https://doi.org/10.1152/ajprenal.00319.2019Rodrigues-Díez, R., Aroeira, L.S., Orejudo, M., et al. (2014) IL-17A Is a Novel Player in Dialysis-Induced Peritoneal Damage. Kidney International, 86, 303-315. <br>https://doi.org/10.1038/ki.2014.33Shang, J., He, Q., Chen, Y., et al. (2019) miR-15a-5p Suppresses Inflammation and Fibrosis of Peritoneal Mesothelial Cells Induced by Peritoneal Dialysis via Targeting VEGFA. Journal of Cellular Physiology, 234, 9746-9755.
<br>https://doi.org/10.1002/jcp.27660Che, M., Shi, T., Feng, S., et al. (2017) The MicroRNA-199a/214 Cluster Targets E-Cadherin and Claudin-2 and Promotes High Glucose-Induced Peritoneal Fibrosis. Journal of the American Society of Nephrology, 28, 2459-2471.
<br>https://doi.org/10.1681/ASN.2016060663Gao, Q., Xu, L., Yang, Q. and Guan, T.J. (2019) MicroRNA-21 Contributes to High Glucose-Induced Fibrosis in Peritoneal Mesothelial Cells in Rat Models by Activation of the Ras-MAPK Signaling Pathway via Sprouty-1. Journal of Cellular Physiology, 234, 5915-5925. <br>https://doi.org/10.1002/jcp.26941Wu, J., Huang, Q., Li, P., et al. (2019) MicroRNA-145 Promotes the Epithelial-Mesenchymal Transition in Peritoneal Dialysis-Associated Fibrosis by Suppressing Fibroblast Growth Factor 10. Journal of Biological Chemistry, 294, 15052-15067. <br>https://doi.org/10.1074/jbc.RA119.007404李勰家, 周循, 孙林, 刘伏友, 肖力, 刘虹, 张磊. MicroRNA-302c通过结缔组织生长因子调控腹膜透析相关腹膜纤维化[J]. 中国血液净化, 2019, 18(3): 192-196.Karagur, E.R., Ozay, C., Mammadov, R. and Akca, H. (2018) Anti-Invasive Effect of Cyclamen pseudibericum Extract on A549 Non-Small Cell Lung Carcinoma Cells via Inhibition of ZEB1 Mediated by miR-200c. Journal of Natural Medicines, 72, 686-693. <br>https://doi.org/10.1007/s11418-018-1204-zWei, X., Huang, H., Bao, Y., et al. (2019) Novel Long Non-Coding RNA AV310809 Promotes TGF-β1 Induced Epithelial-Mesenchymal Transition of Human Peritoneal Mesothelial Cells via Activation of the Wnt2/β-Catenin Signaling Pathway. Biochemical and Biophysical Research Communications, 513, 119-126.
<br>https://doi.org/10.1016/j.bbrc.2019.03.071Zhang, X.W., Wang, L. and Ding, H. (2019) Long Noncoding RNA AK089579 Inhibits Epithelial-to-Mesenchymal Transition of Peritoneal Mesothelial Cells by Competitively Binding to microRNA-296-3p via DOK2 in Peritoneal Fibrosis. FASEB Journal, 33, 5112-5125. <br>https://doi.org/10.1096/fj.201801111RRSzeto, C.-C., Chow, K.-M., Lam, C.W.-K., Leung, C.B., Kwan, B.C.-H., Chung, K.-Y., Law, M.-C. and Li, P.K.-T. (2007) Clinical Biocompatibility of a Neutral Peritoneal Dialysis Solution with Minimal Glucose-Degradation Products—A 1-Year Randomized Control Trial. Nephrology Dialysis Transplantation, 22, 552-559.
<br>https://doi.org/10.1093/ndt/gfl559Lopes, B.D., Coester, A.M., Noordzij, M., Smit, W., Struijk, D.G., Rogers, S., de Waart Dirk, R. and Krediet, R.T. (2011) Variability of Effluent Cancer Antigen 125 and Interleukin-6 Determination in Peritoneal Dialysis Patients. Nephrology Dialysis Transplantation, 26, 3739-3744. <br>https://doi.org/10.1093/ndt/gfr170Evans, I. (2015) An Overview of VEGF-Mediated Signal Transduction. Methods in Molecular Biology, 1332, 91-120.
<br>https://doi.org/10.1007/978-1-4939-2917-7_7Sakai, N., Chun, J., Duffield, J.S., Wada, T., Luster, A.D. and Tager, A.M. (2013) LPA1-Induced Cytoskeleton Reorganization Drives Fibrosis through CTGF-Dependent Fibroblast Proliferation. FASEB Journal, 27, 1830-1846.
<br>https://doi.org/10.1096/fj.12-219378Abrahams, A.C., Habib, S.M., Dendooven, A., et al. (2014) Patients with Encapsulating Peritoneal Sclerosis Have Increased Peritoneal Expression of Connective Tissue Growth Factor (CCN2), Transforming Growth Factor-β1, and Vascular Endothelial Growth Factor. PLoS ONE, 9, e112050. <br>https://doi.org/10.1371/journal.pone.0112050Kim, Y.C., Kim, K.H., Lee, S., Jo, J.-W., Park, J.Y., Park, M.-S., Tsogbadrakh, B., Lee, J.P., Lee, J.W., Kim, D.K., Oh, K.-H., Jang, I.-J., Kim, Y.S., Cha, R.-H. and Yang, S.H. (2019) ST2 Blockade Mitigates Peritoneal Fibrosis Induced by TGF-β and High Glucose. Journal of Cellular and Molecular Medicine, 23, 6872-6884.
<br>https://doi.org/10.1111/jcmm.14571Barreto, D.L., Coester, A.M., Struijk, D.G. and Krediet, R.T. (2013) Can Effluent Matrix Metalloproteinase 2 and Plasminogen Activator Inhibitor 1 Be Used as Biomarkers of Peritoneal Membrane Alterations in Peritoneal Dialysis Patients? Peritoneal Dialysis International, 33, 529-537. <br>https://doi.org/10.3747/pdi.2012.01063Sampimon, D.E., Coester, A.M., Struijk, D.G. and Krediet, R.T. (2011) The Time Course of Peritoneal Transport Parameters in Peritoneal Dialysis Patients Who Develop Encapsulating Peritoneal Sclerosis. Nephrology Dialysis Transplantation, 26, 291-298. <br>https://doi.org/10.1093/ndt/gfq343Reyes, M.-J.F., Bajo, M.-A., Hevía, C., Del Peso, G., Ros, S., de Miguel, A.G., Cirugeda, A., Castro, M.-J., Sánchez-Tomero, J.A. and Selgas, R. (2007) Inherent High Peritoneal Transport and Ultrafiltration Deficiency: Their Mid-Term Clinical Relevance. Nephrology Dialysis Transplantation, 22, 218-223. <br>https://doi.org/10.1093/ndt/gfl529Setyapranata, S. and Holt, S.G. (2015) The Gut in Older Patients on Peritoneal Dialysis. Peritoneal Dialysis International, 35, 650-654. <br>https://doi.org/10.3747/pdi.2014.00341Bozkurt, D., Sarsik, B., Hur, E., et al. (2011) A Novel Angiogenesis Inhibitor, Sunitinib Malate, in Encapsulating Peritoneal Sclerosis. Journal of Nephrology, 24, 359-365. <br>https://doi.org/10.5301/JN.2011.6257Washida, N., Wakino, S., Tonozuka, Y., et al. (2011) Rho-Kinase Inhibition Ameliorates Peritoneal Fibrosis and Angiogenesis in a Rat Model of Peritoneal Sclerosis. Nephrology Dialysis Transplantation, 26, 2770-2779.
<br>https://doi.org/10.1093/ndt/gfr012Peng, W., Zhou, Q., Ao, X., Tang, R. and Xiao, Z. (2013) Inhibition of Rho-Kinase Alleviates Peritoneal Fibrosis and Angiogenesis in a Rat Model of Peritoneal Dialysis. Renal Failure, 35, 958-966.
<br>https://doi.org/10.3109/0886022X.2013.808565Busnadiego, O., Loureiro-Álvarez, J., Sandoval, P., et al. (2015) A Pathogenetic Role for Endothelin-1 in Peritoneal Dialysis-Associated Fibrosis. Journal of the American Society of Nephrology, 26, 173-182.
<br>https://doi.org/10.1681/ASN.2013070799周瑛, 傅鹏. 他汀类药物对肾脏保护作用的研究进展[J]. 医学综述, 2016, 22(8): 1547-1550.熊燕移, 李敏芝, 史伟文, 张莞灵, 卓华钦. 乌司他丁对腹膜透析相关性腹膜纤维化大鼠细胞因子表达的影响[J]. 中华实用诊断与治疗杂志, 2016, 30(8): 747-749.Zhao, J.L., Zhang, T., Shao, X., Zhu, J.J. and Guo, M.Z. (2019) Curcumin Ameliorates Peritoneal Fibrosis via Inhibition of Transforming Growth Factor-Activated Kinase 1 (TAK1) Pathway in a Rat Model of Peritoneal Dialysis. BMC Complementary and Alternative Medicine, 19, 280. <br>https://doi.org/10.1186/s12906-019-2702-6陈珊珊, 岳英丽, 刘东海. 灵芝多糖对腹膜透析大鼠Smad3/CTGF通路及腹膜纤维化的影响[J]. 中国药师, 2021, 24(2): 247-251.Li, Z., Zhang, L., He, W., Zhu, C., Yang, J. and Sheng, M. (2014) Astragalus Membranaceus Inhibits Peritoneal Fibrosis via Monocyte Chemoattractant Protein (MCP)-1 and the Transforming Growth Factor-β1 (TGF-β1) Pathway in Rats Submitted to Peritoneal Dialysis. International Journal of Molecular Sciences, 15, 12959-12971.
<br>https://doi.org/10.3390/ijms150712959杨劲松, 李正红, 张旭, 盛梅笑. 黄芪甲苷对高糖腹膜透析液诱导人腹膜间皮细胞表达致纤维化因子的影响[J]. 中国中医药信息杂志, 2014, 21(7): 36-39.寿苗林, 李素波, 张小云. 丹参酮IIA对腹膜透析患者慢性炎症的调节作用[J]. 医学研究杂志, 2015, 44(2): 130-132.陈利涛. 川芎嗪对高糖或TNFα诱导后人腹膜间皮细胞IL6和IL8表达影响的实验研究[D]: [硕士学位论文]. 南京: 南京中医药大学, 2011.张露. 黄芪甲苷干预腹膜间皮细胞表型转化的分子机制研究[D]: [博士学位论文]. 南京: 南京中医药大学, 2017.